4 ways AI is shaping the future of Life Sciences
There’s no denying it; pharma is in its innovation era. The life sciences industry is already...
Read More
Tag: AI
Teva and Immunai partner to improve clinical decision making
The companies will focus on mechanisms of action, dose selection and biomarker analyses
Read More
NHS Trust to evaluate AI software for prostate cancer diagnosis
It is hoped that the tool will improve the diagnostic pathway and free up radiologists’ time
Read More
Ifs, bots and maybes
Our future robot overlords are playing the long game
Read More
CellVoyant secures £7.6 million AI stem cell boost
CellVoyant’s platform combines AI with live cell imaging
Read More
AstraZeneca and SAS link up on AI and analytics
Collaboration will enable teams across the organisation to increase clinical research innovation
Read More
Momentum for Poolbeg and CytoReason’s AI collaboration
Partnership establishes several influenza therapy targets using artificial intelligence
Read More
AstraZeneca and Clinithink launch lung cancer AI project
AI processes could detect early-stage lung cancer from unstructured medical notes
Read More
PhoreMost and ThinkCyte partner to develop AI-based drug discovery
The partnership combines systems in order to identify subtle phenotypic changes in living cells
Read More
Turbine boosts AI platform to deliver cancer treatments
€20m financing will focus on treatment pathways, new partnerships and team expansion
Read More
Brainomix and Visionable announce AI partnership
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK
Read More
Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership
Link up will utilise Brainomix’s AI software for the assessment of idiopathic pulmonary fibrosis
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
